tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Eckard, 18 are a BUY (94.74%), 1 are a HOLD (5.26%).
Analyst Jonathan Eckard, carries an average stock price target met ratio of 62.96% that have a potential upside of 25.02% achieved within 298 days. Previously, Jonathan Eckard worked at BARCLAYS, CITI.
Jonathan Eckard’s has documented 37 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ALKS, Alkermes Plc at 29-Jul-2016.
Analyst best performing recommendations are on AMRN (AMARIN PLC).
The best stock recommendation documented was for AMRN (AMARIN PLC) at 11/10/2014. The price target of $23 was fulfilled within 8 days with a profit of $6.35 (38.14%) receiving and performance score of 47.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 10-Nov-2020
$19
$13
3 years 4 days ago
(27-Sep-2023)
12/25 (48%)
$0.42 (2.26%)
39
Buy Since 12-Jan-2022
$19
$15
3 years 4 days ago
(27-Sep-2023)
3/16 (18.75%)
$0.42 (2.26%)
57
Buy Since 03-Aug-2023
$19
$19
3 years 4 days ago
(27-Sep-2023)
11/14 (78.57%)
$0.42 (2.26%)
66
Buy Since 03-Aug-2023
$19
$20
3 years 4 days ago
(27-Sep-2023)
2/8 (25%)
$0.42 (2.26%)
86
Buy Since 10-Nov-2020
$19
$18
3 years 5 days ago
(26-Sep-2023)
6/27 (22.22%)
$0.29 (1.55%)
66
